SamaCare, a workflow platform for suppliers providing specialty remedy, introduced it secured $17 million in an oversubscribed Collection B funding spherical.
New investor Questa Capital led the spherical, with participation from current traders South Park Commons and Vive Collective.
WHAT IT DOES
The California-based firm gives a cloud-based workflow automation platform to assist suppliers get hold of prior authorization for specialty drug drugs, verify enrollment, and confirm advantages. It additionally works with pharmaceutical corporations to supply knowledge analytics to assist enhance entry to their therapies.
The corporate will use the funds to broaden its Script-to-Remedy Working System, which can leverage AI for administrative duties, create a post-prescription workflow, accumulate knowledge insights and improve collaboration between suppliers’ places of work.
“SamaCare plans to speculate the funds to construct the excellent Script-to-Remedy Working System, enhancing our specialty prior auth platform’s capabilities for sufferers, suppliers, and pharmaceutical corporations,” Syam Palakurthy, founder and CEO of SamaCare, informed MobiHealthNews in an electronic mail.
“This implies constructing into our platform extra collaboration options, AI-based steerage, and knowledge insights that collectively allow our prospects to make sure that sufferers overcome administrative and monetary obstacles to start out on remedy.”
MARKET SNAPSHOT
SamaCare closed a $12 million Collection A spherical in 2022.
Different corporations providing workflow automation platforms embody Cerner, which was acquired by enterprise software program big Oracle in 2021 for $28.3 billion, and Epic, which gives scientific and administrative workflow instruments.
